Evaluation of O 3 -, O 21 -Di-( N 1 -methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl)17-hydroxy-5β-pregnan-20-one as a novel potential antiangiogenic codrug

Author: Howard-Sparks Michelle   Al-Ghananeem Abeer M.   Pearson Andrew P.   Crooks Peter A.  

Publisher: Informa Healthcare

ISSN: 1475-6366

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol.20, Iss.5, 2005-10, pp. : 417-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content